{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:42:18Z","timestamp":1789864938523,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.ejso.2008.12.002","type":"journal-article","created":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T14:16:28Z","timestamp":1231337788000},"page":"605-610","source":"Crossref","is-referenced-by-count":59,"title":["Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas"],"prefix":"10.1016","volume":"35","author":[{"given":"J.K.","family":"Pine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.G.","family":"Fusai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.R.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.V.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.H.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2008.12.002_bib1","unstructured":"Office of National Statistics. Cancer survival: cancer survival trends by period of diagnosis and sex age-standardised relative survival at one and five years, and average increase in relative survival between successive five-year periods of diagnosis, 1971\u20131990; 2005."},{"key":"10.1016\/j.ejso.2008.12.002_bib2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00268-002-6659-z","article-title":"Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience","volume":"27","author":"Richter","year":"2003","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib3","first-page":"657","article-title":"Malignant tumours in the head of the pancreas and the periampullary region. Diagnostic and prognostic aspects","volume":"14","author":"Griffanti-Bartoli","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2008.12.002_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s004230050102","article-title":"Pathology and biology of pancreatic ductal adenocarcinoma","volume":"383","author":"Hermanek","year":"1998","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF02482964","article-title":"The prognostic significance of lymph node metastases and intrapancreatic perineural invasion in pancreatic cancer after curative resection","volume":"29","author":"Ozaki","year":"1999","journal-title":"Surg Today"},{"key":"10.1016\/j.ejso.2008.12.002_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9610(05)80406-4","article-title":"Resection of pancreatic adenocarcinoma: prognostic indicators for survival","volume":"195","author":"Greer","year":"1993","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1096-9098(200004)73:4<212::AID-JSO5>3.0.CO;2-D","article-title":"Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas","volume":"73","author":"Benassi","year":"2000","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2008.12.002_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00000658-199709000-00004","article-title":"Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes","volume":"226","author":"Yeo","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000658-199602000-00006","article-title":"Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy","volume":"223","author":"Fortner","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000658-200209000-00012","article-title":"Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomised controlled trial evaluating survival, morbidity and mortality","volume":"236","author":"Yeo","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2008.12.002_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2008.12.002_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjc.6602305","article-title":"Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas","volume":"92","author":"Jamieson","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2008.12.002_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1080\/00365520601058452","article-title":"Predictive factors in pancreatic ductal adenocarcinoma: role of inflammatory response","volume":"42","author":"Tingstedt","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejso.2008.12.002_bib15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/bjs.5397","article-title":"Redefining the R1 resection in pancreatic cancer","volume":"93","author":"Verbeke","year":"2006","journal-title":"Br J\u00a0Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000094562","article-title":"Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer","volume":"6","author":"Glen","year":"2006","journal-title":"Pancreatology"},{"key":"10.1016\/j.ejso.2008.12.002_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1097-0142(19850715)56:2<397::AID-CNCR2820560232>3.0.CO;2-I","article-title":"Pancreatic cancer. Assessment of prognosis by clinical presentation","volume":"56","author":"Kalser","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2008.12.002_bib18","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1080\/00365520510023819","article-title":"Gemcitabine treatment in patients with inoperable locally advanced\/metastatic pancreatic caner and prognostic factors","volume":"40","author":"Sezgin","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejso.2008.12.002_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.mcg.0000225657.30803.9d","article-title":"Survival and prognostic factors of unresectable pancreatic cancer","volume":"42","author":"Park","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejso.2008.12.002_bib20","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9","article-title":"Acute-phase protein response and survival duration of patients with pancreatic cancer","volume":"75","author":"Falconer","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2008.12.002_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/ejso.2002.1405","article-title":"Prognostic factors in the palliation of pancreatic cancer","volume":"29","author":"Engelken","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2008.12.002_bib22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejso.2008.12.002_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000012186","article-title":"Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy","volume":"59","author":"Ueno","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.ejso.2008.12.002_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1207\/S15327914NC3701_4","article-title":"Prognostic factors in advanced gastrointestinal cancer patients with weight loss","volume":"37","author":"O'Gorman","year":"2000","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.ejso.2008.12.002_bib25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/bjs.4864","article-title":"Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy","volume":"92","author":"Jagannath","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib26","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/s00268-002-6232-9","article-title":"Effect of internal biliary drainage on plasma levels of endotoxin, cytokines, and C-reactive protein in patients with obstructive jaundice","volume":"26","author":"Padillo","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib27","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2008.12.002_bib28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1023\/B:DDAS.0000034556.48527.6e","article-title":"C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma","volume":"49","author":"Miki","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejso.2008.12.002_bib29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/PL00012351","article-title":"Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia","volume":"23","author":"Fearon","year":"1999","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jjco\/hyl144","article-title":"Prognostic factors in gemcitabine refractory advanced pancreatic cancer patients","volume":"37","author":"Nakachi","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejso.2008.12.002_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/bjs.4038","article-title":"Systemic inflammatory response predicts survival following curative resection of colorectal cancer","volume":"90","author":"McMillan","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2008.12.002_bib32","first-page":"586","article-title":"Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice","volume":"63","author":"Yau","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2008.12.002_bib33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2001","journal-title":"J Am Med Assoc"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798308018519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798308018519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T02:42:51Z","timestamp":1558060971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798308018519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0748798308018519"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2008.12.002","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}